|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Markson G, Kiel C, Hyde R, Brown S,
Charalabous P, Bremm A, Semple J, Woodsmith J, Duley S,
Salehi-Ashtiani K, et al: Analysis of the human E2 ubiquitin
conjugating enzyme protein interaction network. Genome Res.
19:1905–1911. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shekhar MP, Lyakhovich A, Visscher DW,
Heng H and Kondrat N: Rad6 overexpression induces multinucleation,
centrosome amplification, abnormal mitosis, aneuploidy, and
transformation. Cancer Res. 62:2115–2124. 2002.PubMed/NCBI
|
|
5
|
Dong M, Pang X, Xu Y, Wen F and Zhang Y:
Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer
cell proliferation in vitro. Int J Mol Sci. 14:11061–11071. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shuliang S, Lei C, Guangwu J and Changjie
L: Involvement of ubiquitin-conjugating enzyme E2C in proliferation
and invasion of prostate carcinoma cells. Oncol Res. 21:121–127.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie C, Powell C, Yao M, Wu J and Dong Q:
Ubiquitin-conjugating enzyme E2C: A potential cancer biomarker. Int
J Biochem Cell Biol. 47:113–117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hodson C, Purkiss A, Miles JA and Walden
H: Structure of the human FANCL RING-Ube2T complex reveals
determinants of cognate E3-E2 selection. Structure. 22:337–344.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ramaekers CH, van den Beucken T, Meng A,
Kassam S, Thoms J, Bristow RG and Wouters BG: Hypoxia disrupts the
Fanconi anemia pathway and sensitizes cells to chemotherapy through
regulation of UBE2T. Radiother Oncol. 101:190–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ueki T, Park JH, Nishidate T, Kijima K,
Hirata K, Nakamura Y and Katagiri T: Ubiquitination and
downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T
overexpression in human breast cancer cells. Cancer Res.
69:8752–8760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hao J, Xu A, Xie X, Hao J, Tian T, Gao S,
Xiao X and He D: Elevated expression of UBE2T in lung cancer tumors
and cell lines. Tumour Biol. 29:195–203. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakayama KI and Nakayama K: Ubiquitin
ligases: Cell-cycle control and cancer. Nat Rev Cancer. 6:369–381.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hoeller D, Hecker CM and Dikic I:
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat
Rev Cancer. 6:776–788. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Longerich S, Kwon Y, Tsai MS, Hlaing AS,
Kupfer GM and Sung P: Regulation of FANCD2 and FANCI
monoubiquitination by their interaction and by DNA. Nucleic Acids
Res. 42:5657–5670. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sato K, Toda K, Ishiai M, Takata M and
Kurumizaka H: DNA robustly stimulates FANCD2 monoubiquitylation in
the complex with FANCI. Nucleic Acids Res. 40:4553–4561. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alpi A, Langevin F, Mosedale G, Machida
YJ, Dutta A and Patel KJ: UBE2T, the Fanconi anemia core complex,
and FANCD2 are recruited independently to chromatin: A basis for
the regulation of FANCD2 monoubiquitination. Mol Cell Biol.
27:8421–8430. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Machida YJ, Machida Y, Chen Y, Gurtan AM,
Kupfer GM, D'Andrea AD and Dutta A: UBE2T is the E2 in the Fanconi
anemia pathway and undergoes negative autoregulation. Mol Cell.
23:589–596. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Corson TW, Huang A, Tsao MS and Gallie BL:
KIF14 is a candidate oncogene in the 1q minimal region of genomic
gain in multiple cancers. Oncogene. 24:4741–4753. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilson WR and Hay MP: Targeting hypoxia in
cancer therapy. Nat Rev Cancer. 11:393–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ren B, Cam H, Takahashi Y, Volkert T,
Terragni J, Young RA and Dynlacht BD: E2F integrates cell cycle
progression with DNA repair, replication, and G(2)/M checkpoints.
Genes Dev. 16:245–256. 2002. View Article : Google Scholar : PubMed/NCBI
|
